Market Research Future published a Half-Cooked research report on “Global Erectile Dysfunction Drugs Market Research Report – Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Global market of erectile dysfunction drugs is expected to reach USD 2.95 billion in 2023 from USD 1.65 billion in 2016 over the forecast period 2017-2023.
Erectile Dysfunction is the inability to maintain sufficient for satisfactory sexual performance. Management of this disorder includes medical history, sexual history and psychological history of a person. There are number of drugs available for the treatment of erectile dysfunction which include both branded and generic drugs. Changing lifestyle and increase in lifestyle disorders, availability of wide range of drugs for the treatment of erectile.
Stress and mental health concerns may worsen the problem of erectile dysfunction. Physical and psychological issues may also cause erectile dysfunction. The market of erectile dysfunction drugs is driven by the number of drugs available in the market and increasing number of men suffering from this disorder. There is also an increase in the competition among the major market players. According to a trial conducted by the American Urological Association (AUA) Consensus Panel on Erectile Dysfunction, 36% to 76% of patients on erectile dysfunction drug were able to achieve intercourse during treatment.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1313
The Market for Erectile Dysfunction Drugs is growing rapidly and expected to continue its growth in near future. However, factors such as growing threat from counterfeit drugs, prevalence of STDs in erectile dysfunction drug users, and shrinking insurance coverage for ED treatment will hamper the growth of global erectile dysfunction market.
Global Erectile Dysfunction Drugs Market – Major Players
Key players in Erectile Dysfunction Drugs Market are: Pfizer Inc. (U.S), Bayer AG (Germany), Eli Lily & Co. (U.S), Dong–A Pharmaceutical Co. Ltd. (South Korea), Apricus Biosciences Inc. (U.S), S.K. Chemicals Co. Ltd. (South Korea), Apricus Biosciences Inc. (U.S).
Pfizer Inc. is an American global pharmaceutical corporation headquartered in New York City. It is among the world’s largest pharmaceutical companies. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Viagra drug for erectile dysfunction treatment manufactured by the company. In June 1, 2017, Pfizer Limited (India) acquired AstraZeneca’s Neksium.
Bayer AG is a chemical, pharmaceutical and life science company. It is one of the major players manufacturing drugs for erectile dysfunction. Levitra is a product offered by the company for this disorder. It is a major competitor for Pfizer in this market.
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Its products are sold in approximately 125 countries. The company manufactures a drug named Cialis for erectile dysfunction. In January 2017, the Eli Lilly Company was awarded as world’s most ethical company.
Global Erectile Dysfunction Drugs Market – Regional Analysis
Globally, erectile dysfunction drugs market consists of four regions Americas, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market. Europe is the second largest market. Asia Pacific shows fastest growth in this market. The market shows steady growth in Middle East and Africa.
Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/erectile-dysfunction-drugs-market-1313
Global Erectile Dysfunction Drugs Market – Segmentation
Global Erectile dysfunction drugs market has been segmented on the basis of product which includes Viagra, Cialis, Levitra, Stendra, Zydena and other drugs and on the basis of end users the market is segmented into Hospitals, clinics, pharmaceutical companies and others.
Table of Contents
- Report Prologue
- Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
- Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
- Market Dynamic
…. Continued
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/1313
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
